Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Shares of CBS Corporation ( CBS - Analyst Report ) reached a new 52-week high of $46.13 on Friday, Mar 8, gaining momentum from the company’s strategic initiatives focused on driving growth through affiliate and subscription deals coupled with the restructuring of CBS Outdoor. This Zacks Rank #2 (Buy) mass media company eventually closed at $46.00, recording a healthy return of 17.4% year-to-date.
Alongside, companies like The J. M. Smucker Company ( SJM - Analyst Report ) , Molson Coors Brewing Company ( TAP - Analyst Report ) , and Sysco Corporation ( SYY - Snapshot Report ) crafted new 52-week highs on Friday.
Drivers that Triggered Momentum
CBS remains well positioned to drive growth in the coming quarters through its strategic initiatives focused on increasing subscription based revenue channels. The company remains optimistic and expects growth momentum to continue in 2013 based on reverse compensation from affiliates, strong demand of its content, digital distribution, syndication sales and retransmission consent.
CBS is eyeing around $1 billion in retransmission and reverse compensation revenues by 2017. The company also remains positive about CBS Television Network being the growth driver.
Moreover, in a strategic move to unlock the value of the assets, CBS decided to convert its CBS Outdoor operations in North America and South America into a real estate investment trust (“REIT”) and divest its Outdoor businesses in Europe and Asia.
We believe CBS Corporation’s decision regarding the Outdoor business would augur well for the company, as it would lower its dependency on advertising, which remains vulnerable to the economy’s health.
Stock’s Key Indicators
CBS currently trades at a forward P/E of 15.54x, a 9.7% discount with the industry average of 17.21x. Its price-to-sales ratio of 1.99 is also below the industry average of 2.97. Moreover, the company generates return-on-equity (ROE) and return-on-investment (ROI) of 16.0% and 10.1%, respectively. The company’s strong fundamentals are well supported by its long-term estimated EPS growth rate of 11.7%.
Read the full Analyst Report on CBS
Read the full Analyst Report on SJM
Read the full Analyst Report on TAP
Read the full Snapshot Report on SYY